June_Pharmaceuticals|U.S. Biosafety Act: CDMOs are grabbing the business opportunities
In the wake of the COVID-19 outbreak, drug shortages, costly drug price pressures, and geopolitical supply chain risks continue to underscore the importance of resilient manufacturing and a stable supply chain. ... Read more